Paroxetine en es it fr


Paroxetine Marchi, Paroxetine Analoghi

Paroxetine Marchi miscela

  • No information avaliable
  • Paroxetine Formula chimica


    Paroxetine RX link

    Paroxetine FDA foglio

    Paroxetine FDA

    Paroxetine DMS (foglio di materiale di sicurezza)

    Paroxetine MSDS

    Paroxetine Sintesi di riferimento

    JA Christensen, Squires RF, US Pat. 3,912,743 (1975)

    Paroxetine Peso molecolare

    329.365 g/mol

    Paroxetine Temperatura di fusione

    129-131 oC

    Paroxetine H2O Solubilita

    Nessuna informazione disponibile

    Paroxetine Stato


    Paroxetine LogP


    Paroxetine Forme di dosaggio


    Paroxetine Indicazione

    Per il trattamento della depressione, la depressione accompagnata da ansia, disturbo ossessivo compulsivo e attacchi di panico

    Paroxetine Farmacologia

    Paroxetina, un farmaco antidepressivo della inibitori selettivi della ricaptazione della serotonina (SSRI) tipo, non ha metaboliti attivi ed ha la più alta specificità per i recettori della serotonina di tutti i farmaci SSRI. E 'usato per il trattamento di depressione resistente ad altri antidepressivi, depressione complicata da ansia, attacchi di panico, disturbo d'ansia sociale e generale, disturbo ossessivo-compulsivo (OCD), disforico premestruale disordine, l'eiaculazione precoce, e vampate di calore della menopausa nelle donne con carcinoma mammario.

    Paroxetine Assorbimento

    completamente assorbito dopo somministrazione orale

    Paroxetine Tossicita

    LD50 = 500mg/kg (per via orale nei topi), Coma, vertigini, sonnolenza, rossore al viso, nausea, sudorazione, tremore, vomito

    Paroxetine Informazioni paziente

    Prescribers or other health professionals should inform patients, their families, and their caregivers about the benefits and risks associated with treatment with PAXIL and should counsel them in its appropriate use. A patient Medication Guide About Using Antidepressants in Children and Teenagers is available for PAXIL. The prescriber or health professional should instruct patients, their families, and their caregivers to read the Medication Guide and should assist them in understanding its contents. Patients should be given the opportunity to discuss the contents of the Medication Guide and to obtain answers to any questions they may have. The complete text of the Medication Guide is reprinted at the end of this document.

    Patients should be advised of the following issues and asked to alert their prescriber if these occur while taking PAXIL.

    Clinical Worsening and Suicide Risk: Patients, their families, and their caregivers should be encouraged to be alert to the emergence of anxiety, agitation, panic attacks, insomnia, irritability, hostility, aggressiveness, impulsivity, akathisia (psychomotor restlessness), hypomania, mania, other unusual changes in behavior, worsening of depression, and suicidal ideation, especially early during antidepressant treatment and when the dose is adjusted up or down. Families and caregivers of patients should be advised to observe for the emergence of such symptoms on a day-to-day basis, since changes may be abrupt. Such symptoms should be reported to the patientís prescriber or health professional, especially if they are severe, abrupt in onset, or were not part of the patientís presenting symptoms. Symptoms such as these may be associated with an increased risk for suicidal thinking and behavior and indicate a need for very close monitoring and possibly changes in the medication.

    Drugs That Interfere With Hemostasis (NSAIDs, Aspirin, Warfarin, etc.)

    Patients should be cautioned about the concomitant use of paroxetine and NSAIDs, aspirin, or other drugs that affect coagulation since the combined use of psychotropic drugs that interfere with serotonin reuptake and these agents has been associated with an increased risk of bleeding.

    Interference With Cognitive and Motor Performance

    Any psychoactive drug may impair judgment, thinking, or motor skills. Although in controlled studies PAXIL has not been shown to impair psychomotor performance, patients should be cautioned about operating hazardous machinery, including automobiles, until they are reasonably certain that therapy with PAXIL does not affect their ability to engage in such activities.

    Completing Course of Therapy

    While patients may notice improvement with treatment with PAXIL in 1 to 4 weeks, they should be advised to continue therapy as directed.

    Concomitant Medication

    Patients should be advised to inform their physician if they are taking, or plan to take, any prescription or over-the-counter drugs, since there is a potential for interactions.


    Although PAXIL has not been shown to increase the impairment of mental and motor skills caused by alcohol, patients should be advised to avoid alcohol while taking PAXIL.


    Patients should be advised to notify their physician if they become pregnant or intend to become pregnant during therapy.


    Patients should be advised to notify their physician if they are breast-feeding an infant.

    Medication Guide

    PAXIL® (PAX-il) (paroxetine hydrochloride) Tablets and Oral Solution

    About Using Antidepressants in Children and Teenagers

    What is the most important information I should know if my child is being prescribed an antidepressant?

    Parents or guardians need to think about 4 important things when their child is prescribed an antidepressant:

    1. There is a risk of suicidal thoughts or actions
    2. How to try to prevent suicidal thoughts or actions in your child
    3. You should watch for certain signs if your child is taking an antidepressant
    4. There are benefits and risks when using antidepressants

    1. There is a Risk of Suicidal Thoughts or Actions

    Children and teenagers sometimes think about suicide, and many report trying to kill themselves.

    Antidepressants increase suicidal thoughts and actions in some children and teenagers. But suicidal thoughts and actions can also be caused by depression, a serious medical condition that is commonly treated with antidepressants. Thinking about killing yourself or trying to kill yourself is called suicidality or being suicidal.

    A large study combined the results of 24 different studies of children and teenagers with depression or other illnesses. In these studies, patients took either a placebo (sugar pill) or an antidepressant for 1 to 4 months. No one committed suicide in these studies, but some patients became suicidal. On sugar pills, 2 out of every 100 became suicidal. On the antidepressants, 4 out of every 100 patients became suicidal.

    For some children and teenagers, the risks of suicidal actions may be especially high. These include patients with

    • Bipolar illness (sometimes called manic-depressive illness)
    • A family history of bipolar illness
    • A personal or family history of attempting suicide

    If any of these are present, make sure you tell your healthcare provider before your child takes an antidepressant.

    2. How to Try to Prevent Suicidal Thoughts and Actions

    To try to prevent suicidal thoughts and actions in your child, pay close attention to changes in her or his moods or actions, especially if the changes occur suddenly. Other important people in your child's life can help by paying attention as well (e.g., your child, brothers and sisters, teachers, and other important people). The changes to look out for are listed in Section 3, on what to watch for.

    Whenever an antidepressant is started or its dose is changed, pay close attention to your child.

    After starting an antidepressant, your child should generally see his or her healthcare provider:

    • Once a week for the first 4 weeks
    • Every 2 weeks for the next 4 weeks
    • After taking the antidepressant for 12 weeks
    • After 12 weeks, follow your healthcare provider's advice about how often to come back
    • More often if problems or questions arise

    You should call your child's healthcare provider between visits if needed.

    3. You Should Watch for Certain Signs If Your Child is Taking an Antidepressant

    Contact your child's healthcare provider right away if your child exhibits any of the following signs for the first time, or if they seem worse, or worry you, your child, or your child's teacher:

    • Thoughts about suicide or dying
    • Attempts to commit suicide
    • New or worse depression
    • New or worse anxiety
    • Feeling very agitated or restless
    • Panic attacks
    • Difficulty sleeping (insomnia)
    • New or worse irritability
    • Acting aggressive, being angry, or violent
    • Acting on dangerous impulses
    • An extreme increase in activity and talking
    • Other unusual changes in behavior or mood

    Never let your child stop taking an antidepressant without first talking to his or her healthcare provider. Stopping an antidepressant suddenly can cause other symptoms.

    4. There are Benefits and Risks When Using Antidepressants

    Antidepressants are used to treat depression and other illnesses. Depression and other illnesses can lead to suicide. In some children and teenagers, treatment with an antidepressant increases suicidal thinking or actions. It is important to discuss all the risks of treating depression and also the risks of not treating it. You and your child should discuss all treatment choices with your healthcare provider, not just the use of antidepressants.

    Other side effects can occur with antidepressants.

    Of all the antidepressants, only fluoxetine (Prozac®) has been FDA approved to treat pediatric depression.

    For obsessive compulsive disorder in children and teenagers, FDA has approved only fluoxetine (Prozac®)*, sertraline (Zoloft®)*, fluvoxamine, and clomipramine (Anafranil®)*.

    Your healthcare provider may suggest other antidepressants based on the past experience of your child or other family members.

    Is this all I need to know if my child is being prescribed an antidepressant?

    No. This is a warning about the risk for suicidality. Other side effects can occur with antidepressants. Be sure to ask your healthcare provider to explain all the side effects of the particular drug he or she is prescribing. Also ask about drugs to avoid when taking an antidepressant. Ask your healthcare provider or pharmacist where to find more information.

    *The following are registered trademarks of their respective manufacturers: Prozac®/Eli Lilly and Company; Zoloft®/Pfizer Pharmaceuticals; Anafranil®/Mallinckrodt Inc.

    This Medication Guide has been approved by the U.S. Food and Drug Administration for all antidepressants.

    Research Triangle Park, NC 27709
    ©2005, GlaxoSmithKline. All rights reserved.

    January 2005

    Paroxetine Atto interessato organismi

    Gli esseri umani e altri mammiferi